z-logo
open-access-imgOpen Access
The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines
Author(s) -
Hideki Miyata,
Tamito Sasaki,
Kenichi Kuwahara,
Masahiro Serikawa,
Kazuaki Chayama
Publication year - 2006
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.28.4.915
Subject(s) - clonogenic assay , protein kinase b , ly294002 , cancer research , biology , tyrosine kinase inhibitor , epidermal growth factor receptor , pi3k/akt/mtor pathway , phosphorylation , signal transduction , cell culture , microbiology and biotechnology , receptor , cancer , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom